Acculi Labs Pvt Ltd, a Bengaluru-based health-technology firm has raised Rs 5 crore (around $700,000) in seed funding from PirE Ventures, an investment firm based out of Mumbai, former said in a statement recently.
Founded in 2017 by Rupam Das, Acculi Labs focuses on patient-centric disease management and diagnostics. Its objective is to make home-based care accessible to all sections of society.
Its flagship product, Lyfas, is a mobile-based clinical-grade digital biomarker tool that allows for disease profiling and monitoring.
“The investment will be used to bring our vision to reality. [Our] R&D will work with new vigour and rigour to simplify healthcare for the needy. [We] will run full business operations to ensure that Lyfas becomes the need of every household, irrespective of geophysical location, as we at Acculi believe that healthcare is the need of people,” Rupam Das, CTO and CEO of Acculi Labs, was quoted as saying.
In September last year, the company had raised an undisclosed sum in pre-seed funding from a group of angel investors and Bengaluru-based Startup Basket.